Real-time assessment of relapse risk based on the WT1 marker in acute leukemia and myelodysplastic syndrome patients after hematopoietic cell transplantation

International Scoring System for Evaluating Prognosis in Myelodysplastic Syndromes

Peter L. Greenberg, Christopher Cox, Michelle M. LeBeau et al. · Blood · 1997 · 4.5K citations · Full text

Medicine, Hematology, Internal Medicine +13

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study

Marilyn L. Slovak, Kenneth J. Kopecky, Peter A. Cassileth et al. · Blood · 2000 · 1.6K citations

Medicine, Hematology, Oncology +10

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using ‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) – a Europe against cancer program

Emmanuel Beillard, Niels Pallisgaard, Vincent H. J. van der Velden et al. · Leukemia · 2003 · 884 citations

Medicine, Molecular Biology, Oncology +16

WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia

Kazushi Inoue, Haruo Sugiyama, Hiroyasu Ogawa et al. · Blood · 1994 · 575 citations · Full text

Medicine, Hematology, Oncology +16

Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

Christoph Schmid, Myriam Labopin, Arnon Nagler et al. · Journal of Clinical Oncology · 2007 · 516 citations · Full text

Medicine, Hematology, Immunology +17